SCHEMBL2865225

SCHEMBL2865225

N#Cc1ccc2c(-c3cccc(F)c3)n[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 11/20 0.59
ITK Q08881 2/20 0.54
TRPA1 O75762 1/20 0.50
SCN5A Q14524 1/20 0.50
SCN9A Q15858 1/20 0.50
MAPK1 P28482 2/20 0.46
MAP2K7 O14733 2/20 0.46
HTR7 P34969 1/20 0.45
MAPKAPK2 P49137 1/20 0.44
MAPKAPK3 Q16644 1/20 0.44
MAPK6 Q16659 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
METAP2 P50579 1/20 0.44
TTK P33981 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864778 0.89 ITK (0.54) MAP2K4ITKHTR7
SCHEMBL2868118 0.80 MAP2K4 (0.48) MAP2K4MAP2K7HTR7TTKADORA2A
SCHEMBL2860721 0.78 AXL (0.61) MAP2K4MAPK1MAP2K7MAPKAPK2MAPKAPK3
SCHEMBL2860957 0.77 AURKA (0.66) MAP2K4ITKMAPK1MAP2K7HTR7
SCHEMBL2859630 0.77 HTR7 (0.44) MAP2K4MAPK1HTR7GABRG2GABRB3
SCHEMBL17696918 0.77 AURKA (0.60) MAP2K4ITKMAPK1MAP2K7MAPKAPK3
SCHEMBL2857604 0.76 HTR7 (0.43) MAP2K4HTR7GABRG2GABRB3GABRA5
SCHEMBL17829602 0.75 MAP2K4 (0.69) MAP2K4ITKMAPK1MAP2K7MAPKAPK2
SCHEMBL27191589 0.75 MAP2K4 (1.00) MAP2K4MAP2K7
SCHEMBL2864133 0.75 NTRK1 (0.53) MAP2K4TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885ITK 3726/4885TRPA1 308/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885ITK 3628/4885TRPA1 755/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885ITK 3726/4885TRPA1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.